Skip to main content
Caplight Logo









Airway Therapeutics

Airway Therapeutics

Private
Marietta, GeorgiaHealthcare & Life Scienceshttps://www.airwaytherapeutics.com/

Last Round

Series E

Extension

Aug 25, 2026

Total Funding Raised

$81.1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Airway Therapeutics is a biopharmaceutical company developing a new class of biologic therapies to prevent and treat respiratory, inflammatory, and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalbiotechprotein therapeuticsrespiratory diseasesurfactant protein DSP-Dlung inflammationbiologicsclinical-stage biotechneonatologycritical care pulmonologydrug developmentrecombinant proteinpharma pipelinedrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Airway Therapeutics Comparables

Compare Airway Therapeutics with similar companies based on industry and business-model similarity.

Airway Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EXO Biologics
86%
Oak Hill Bio
80%
ONY Biotech
79%

Airway Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series E ExtensionAug 25, 2026
Series CJan 8, 2020
Series BApr 17, 2018
VC RoundMar 6, 2017
Series ASep 10, 2014
Seed
Jun 1, 2011

Airway Therapeutics Investors

Notable investors and investment history

Airway Therapeutics investors
InvestorRounds
QCA VenturesSeries A, Series B
QCA VenturesVC Round, Series A, Series B, Series C
Ohio Third FrontierSeries C
CincyTechVC Round, Series A, Seed, Series B, Series C
CincyTechSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2026

    $50M round with Cincinnati Children's participation.

  • Jul 26, 2026

    Monthly visitors grew 39% MoM, from 763 to 1.1K.

Airway Therapeutics Filings

Explore SEC and related filing metadata, where available.

Airway Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Airway Therapeutics's valuation, stock price, and market status.

Is Airway Therapeutics a public or private company?

Airway Therapeutics is a private company.

What is the current stock price of Airway Therapeutics?

Airway Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Airway Therapeutics worth (valuation)?

Valuation information for Airway Therapeutics is not publicly available.

Can I buy Airway Therapeutics stock?

Airway Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Airway Therapeutics's last funding round?

Airway Therapeutics's most recent funding round was Series C on January 8, 2020.

Who are the main investors in Airway Therapeutics?

Key investors in Airway Therapeutics include CincyTech.

Will Airway Therapeutics IPO soon?

No public IPO plans have been announced for Airway Therapeutics.

How can I track Airway Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Airway Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMarietta, Georgia
Employee Range10
Year Founded2011
Last FundingAug 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?